Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection
- 20 May 2022
- journal article
- editorial
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 41 (8), 1124-1126
- https://doi.org/10.1016/j.healun.2022.05.003
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- COVID-19 Therapeutics for Nonhospitalized PatientsJAMA, 2022
- Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in AdolescentsJournal of the Pediatric Infectious Diseases Society, 2022
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodiesNature Medicine, 2022
- Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipientsThe Journal of Heart and Lung Transplantation, 2021
- SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19Emergencias, 2021